Johns Hopkins Medicine Hosts Briefing on COVID-19: One Year Later
Experts will address the lingering effects of COVID-19, treatment options and vaccine effectiveness
WHAT: A Woman’s Journey will host a 90-minute virtual event, “COVID-19: One Year Later,” during which Johns Hopkins Medicine experts will address important issues related to COVID-19 such as new and available treatments and vaccine safety and efficacy. Registrants will learn about the continued urgency of public health measures to mitigate the pandemic despite the introduction of vaccines, what distinguishes the leading vaccine contenders in their methodology, safety and effectiveness, and symptoms and insights surrounding lingering deficits in physical function, mental health and cognition among COVID-19 survivors.
WHY: This briefing provides an opportunity to hear from Johns Hopkins physicians about discoveries and innovations in the prevention, diagnosis and treatment of COVID-19.
WHEN: Wednesday, Feb. 3, 7:30–9 p.m.
WHERE: Virtual event via Zoom
REGISTRATION: Registration for this event is free. Contact Waun’Shae Blount at 410-955-3195 or firstname.lastname@example.org to arrange registration.
WHO: Speakers and topics are as follows.
MODERATOR: Kristen Welker, NBC News. Co-anchor of Weekend TODAY and NBC News Chief White House correspondent. Welker is a hard-hitting political journalist who appears on NBCNews.com and the TV programs Nightly News with Lester Holt, TODAY and Meet the Press.
COVID-19: One Year Later: Lisa Maragakis, M.D., M.P.H., senior director of infection prevention for the Johns Hopkins Health System, will discuss the development of strategies and therapeutics to improve treatment of patients with COVID-19, issues surrounding virus mutation and the continued urgency of public health measures to mitigate the pandemic despite the introduction of vaccines.
Are the Vaccines Safe?: Anna Durbin, M.D., professor at the Johns Hopkins Bloomberg School of Public Health, will discuss the novel messenger RNA technology, used for the first time in history, what distinguishes the leading vaccine contenders in their methodology, safety and effectiveness, and Johns Hopkins’ role in evaluating the Pfizer and Astra Zeneca vaccines.
Lingering Effects of COVID-19: Emily Brigham, M.D., M.H.S., assistant professor of medicine and specialist in pulmonary and critical care medicine, will discuss lingering deficits in physical function, mental health and cognition related to COVID-19. Brigham will also discuss the Johns Hopkins Post-Acute COVID-19 Team (JH PACT) Clinic, one of the first such clinics in the U.S. dedicated to supporting the ongoing recovery of COVID-19 survivors.
More information about the sessions and featured speakers can be found here.To schedule an interview with any of the speakers or to register for the event, please contact Waun’Shae Blount at 410-955-3195 or email@example.com.